Vietnam Medical and Pharmaceutical Investment Joint Stock Company

HOSE:JVC Stock Report

Market Cap: ₫763.9b

Vietnam Medical and Pharmaceutical Investment Management

Management criteria checks 3/4

We currently do not have sufficient information about the CEO.

Key information

Nam Pham

Chief executive officer

₫1.6b

Total compensation

CEO salary percentagen/a
CEO tenure2.8yrs
CEO ownershipn/a
Management average tenure2.2yrs
Board average tenure4yrs

Recent management updates

Recent updates

CEO

Nam Pham

2.8yrs
Tenure
₫1,583,205,009
Compensation

Mr. Nam Thanh Pham is Director of Japan Vietnam Medical Investment and Development Joint Stock Company from December 10, 2021 and was its Deputy Chief Executive Officer since January 01, 2022 and is CEO an...

Leadership Team

NamePositionTenureCompensationOwnership
Nam Pham
Deputy Chairman2.8yrs₫1.58bno data
Do Thi Hoa
Deputy CEO & Member of Management Board3.6yrs₫1.97bno data
Toan Vu
Deputy CEO & Member of Management Board1.6yrs₫737.24mno data
Cuong Nguyen
CFO & Chief Accountant1.3yrsno datano data
2.2yrs
Average Tenure

Experienced Management: JVC's management team is considered experienced (2.2 years average tenure).

Board Members

NamePositionTenureCompensationOwnership
Nam Pham
Deputy Chairman4yrs₫1.58bno data
Hosono Kyohei
Director7.2yrsno datano data
Ho Ngoc
Directorno datano datano data
Nguyen Hanh
Directorno datano datano data
Mark Gillin
Directorno datano datano data
Nguyen Hieu
Director10.5yrsno datano data
Le Thi Ha
Director9.2yrsno datano data
Chi Nguyen
Independent Director1.5yrs₫33.00mno data
Hanh Nguyen
Non-Executive Director4yrs₫1.77bno data
Sy Nguyen
Head of the Supervisory Board4yrsno datano data
Phuong Nguyen
Non-Executive Director4yrs₫468.33mno data
Ha Nguyen
Chairperson of Board of Directors2.6yrs₫114.00mno data
4.0yrs
Average Tenure

Experienced Board: JVC's board of directors are considered experienced (4 years average tenure).

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2025/12/04 21:21
End of Day Share Price 2025/12/04 00:00
Earnings2025/09/30
Annual Earnings2024/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* Example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.

Analyst Sources

Vietnam Medical and Pharmaceutical Investment Joint Stock Company is covered by 1 analysts. 0 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution
Dao Thi NguyenViet Capital Securities Joint Stock Company